Why Spain Works for Biotech / Life Sciences
Funding access (100/100) is a standout for Spain Biotech / Life Sciences companies. The local market has 100 active VC funds, with average seed checks of $800K. Government grant programs include CDTI (Centre for Industrial Technological Development) ($300K) and EIC Accelerator ($2.7M). Non-dilutive capital availability reduces the pressure to give up equity at early stage, which is particularly valuable for capital-efficient Biotech / Life Sciences businesses.
Operational ease (96/100) makes Spain practical for Biotech / Life Sciences founders setting up from scratch. Banking difficulty for foreigners is rated easy. Company formation takes approximately 7 days at a cost of around $2K, with annual compliance costs around $3K. Full foreign ownership is permitted - no local partner required. IP protection quality is rated moderate, which matters for Biotech / Life Sciences businesses with proprietary technology or brand assets.
Family viability (95/100) is a genuine strength for Spain - important for Biotech / Life Sciences founders relocating with a partner or children. The cost of living index is 55 (NYC = 100), with a comfortable family monthly budget of $4K. Safety scores 72/100. International schools are available, and healthcare quality scores 82/100 with private insurance running approximately $200/month.